Sonoma Pharmaceuticals, Inc. (SNOA)
Revenue
$21.92M
TTM · Period ending: · USD
SNOA Revenue
Latest reported$21.92Mperiod ending
Latest reported$21.92Mperiod ending
SNOA TTM Revenue ($2.17M → $21.92M)
TTM revenue
High-resolution chart · PNG
SNOA revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 21,920,000 | |
| 19,529,000 | |
| 17,722,000 | |
| 16,937,000 | |
| 14,912,000 | |
| 14,288,000 | |
| 13,973,000 | |
| 13,547,000 | |
| 12,699,000 | |
| 12,735,000 | |
| 12,310,000 | |
| 12,116,000 | |
| 12,716,000 | |
| 13,272,000 | |
| 12,556,000 | |
| 12,514,000 | |
| 12,927,000 | |
| 12,628,000 | |
| 12,487,000 | |
| 14,521,000 | |
| 16,546,000 | |
| 18,629,000 | |
| 20,784,000 | |
| 20,243,000 | |
| 19,201,000 | |
| 17,929,000 | |
| 17,999,000 | |
| 18,884,000 | |
| 19,096,000 | |
| 18,970,000 | |
| 18,243,000 | |
| 17,806,000 | |
| 17,192,000 | |
| 16,658,000 | |
| 17,032,000 | |
| 15,550,000 | |
| 14,023,000 | |
| 12,826,000 | |
| 12,327,000 | |
| 11,449,000 | |
| 12,705,000 | |
| 13,747,000 | |
| 14,197,000 | |
| 14,932,000 | |
| 14,142,000 | |
| 13,854,000 | |
| 12,788,000 | |
| 12,863,000 | |
| 13,688,000 | |
| 13,668,000 | |
| 14,089,000 | |
| 14,336,000 | |
| 14,773,000 | |
| 15,452,000 | |
| 15,468,000 | |
| 14,718,000 | |
| 13,855,000 | |
| 12,744,000 | |
| 12,104,000 | |
| 11,627,000 | |
| 10,430,000 | |
| 9,754,000 | |
| 9,275,000 | |
| 8,575,000 | |
| 7,781,000 | |
| 7,364,000 | |
| 6,607,000 | |
| 6,215,000 | |
| 6,024,000 | |
| 5,388,000 | |
| 4,839,000 | |
| 4,684,000 | |
| 4,180,000 | |
| 3,835,000 | |
| 4,071,000 | |
| 4,057,000 | |
| 4,332,000 | |
| 4,631,000 | |
| 4,220,000 | |
| 3,919,000 | |
| 3,208,000 | |
| 2,584,000 | |
| 2,172,000 | |
| 1,760,000 | |
| 1,558,000 | |
| 1,356,000 |